These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 25395339

  • 1. Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.
    Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S.
    Immunol Res; 2015 Feb; 61(1-2):35-44. PubMed ID: 25395339
    [Abstract] [Full Text] [Related]

  • 2. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S, Kveder T, Ulcova-Gallova Z, Swadzba J, Musial J, Valesini G, Avcin T, Rozman B, Bozic B.
    Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
    Arvieux J, Regnault V, Hachulla E, Darnige L, Roussel B, Bensa JC.
    Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
    [Abstract] [Full Text] [Related]

  • 6. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J, von Landenberg P, Kehrel M, Buhl A, Lackner KJ, Luppa PB.
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [Abstract] [Full Text] [Related]

  • 7. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y.
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Fine specificity of anti-β2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1].
    Nalli C, Andreoli L, Motta M, Norman GL, Shums Z, Binder WL, Nuzzo M, Frassi M, Lojacono A, Meini A, Medeghini V, Avcin T, Meroni PL, Tincani A.
    Reumatismo; 2011 Jul; 63(2):91-6. PubMed ID: 21776445
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M, Buttari B, Capozzi A, Profumo E, Facchiano F, Truglia S, Recalchi S, Alessandri C, Conti F, Misasi R, Valesini G, Riganò R.
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [Abstract] [Full Text] [Related]

  • 11. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).
    Serrano M, Martinez-Flores JA, Norman GL, Naranjo L, Morales JM, Serrano A.
    Front Immunol; 2019 May; 10():1031. PubMed ID: 31134087
    [Abstract] [Full Text] [Related]

  • 12. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR.
    Clin Dev Immunol; 2003 May; 10(2-4):203-11. PubMed ID: 14768953
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oxidatively altered IgG with increased immunoreactivity to β2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells.
    Artenjak A, Omersel J, Ahlin Grabnar P, Mlinarič-Raščan I, Shoenfeld Y, Sodin-Semrl S, Božič B, Čučnik S.
    Lupus; 2015 Apr; 24(4-5):448-62. PubMed ID: 25801888
    [Abstract] [Full Text] [Related]

  • 15. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L, Chighizola CB, Nalli C, Gerosa M, Borghi MO, Pregnolato F, Grossi C, Zanola A, Allegri F, Norman GL, Mahler M, Meroni PL, Tincani A.
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [Abstract] [Full Text] [Related]

  • 16. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
    Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y.
    J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
    [Abstract] [Full Text] [Related]

  • 17. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.
    Chighizola CB, Pregnolato F, Andreoli L, Bodio C, Cesana L, Comerio C, Gerosa M, Grossi C, Kumar R, Lazzaroni MG, Mahler M, Mattia E, Nalli C, Norman GL, Raimondo MG, Ruffatti A, Tonello M, Trespidi L, Tincani A, Borghi MO, Meroni PL.
    J Autoimmun; 2018 Jun; 90():76-83. PubMed ID: 29454510
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
    Rauch J, Salem D, Subang R, Kuwana M, Levine JS.
    Front Immunol; 2018 Jun; 9():2836. PubMed ID: 30619248
    [Abstract] [Full Text] [Related]

  • 20. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.